Charles River Laboratories stock holds near its yearly high on mixed results

Published on 09/22/2026 at 12:15 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Charles River Laboratories stock closed at USD 278.06 on September 18, 2026, 8.3 percent below its yearly high. Q2 revenue fell 2.7 percent to USD 1.00 billion.

CRL, US1598641074, Illustration mit AI erstellt.

Charles River Laboratories stock (ISIN US1598641074) closed at USD 278.06 on the NYSE on September 18, 2026, after a 1.28 percent decline. The price remained 8.3 percent below the 52-week high of USD 303.31, while the latest quarter combined weaker revenue with raised 2026 adjusted guidance.

Revenue falls in Q2

According to Yahoo Finance on September 22, 2026, second-quarter revenue fell 2.7 percent year over year to USD 1.00 billion. Organic growth was 0.1 percent, while Research Models and Services revenue declined 1.8 percent.

The earnings mix was weaker than the revenue line. GAAP earnings changed from a profit of USD 1.06 per share in the prior-year quarter to a loss of USD 0.03 per share in Q2 2026, reflecting a USD 63.7 million loss linked to divestitures. Non-GAAP earnings fell 3.2 percent to USD 3.02 per share, and the non-GAAP operating margin narrowed from 22.1 percent to 20.5 percent.

Guidance points higher

The quarter also contained an operating counterweight. The Discovery and Safety Assessment segment recorded its highest net book-to-bill ratio in nearly four years, and management raised its 2026 organic revenue and non-GAAP earnings outlook, according to Yahoo Finance on September 22, 2026.

Market expectations are tightly aligned with the company forecast. MarketBeat reported on September 21, 2026, that fiscal 2026 earnings guidance stands at USD 11.15 to USD 11.45 per share, compared with analyst expectations of about USD 11.33. The midpoint of USD 11.30 is only USD 0.03 below that consensus figure.

Stock remains below high

The valuation reflects confidence in a recovery but leaves little room for another margin setback. On September 18, 2026, the stock traded between USD 276.01 and USD 282.99, compared with a 52-week range of USD 144.26 to USD 303.31. The latest close was USD 133.80 above the yearly low and USD 25.25 below the yearly high.

Charles River Laboratories stock closes at USD 278.06

Charles River Laboratories stock closed at USD 278.06 in USD on the NYSE on September 18, 2026, down 1.28 percent from the prior close. The market is weighing the raised adjusted outlook against a 2.7 percent quarterly revenue decline and the fall in non-GAAP operating margin to 20.5 percent.